Literature DB >> 18657247

Quality of life in bipolar disorder patients: a comparison with a general population sample.

Luis Gutiérrez-Rojas1, Manuel Gurpegui, José L Ayuso-Mateos, José A Gutiérrez-Ariza, Miguel Ruiz-Veguilla, Dolores Jurado.   

Abstract

OBJECTIVES: To compare the Quality of Life (QoL) of bipolar disorder (BD) patients with that of the general population; and, within the BD patients, to find the demographic and clinical variables associated with low QoL, controlling for the effects of potential confounders.
METHODS: Based on the 25th percentile of the physical (PCS) and the mental (MCS) component scores (PCS <53 and MCS < 50, respectively) of the Medical Outcomes Survey 36-item Short-Form Health-Survey (SF-36) of a general population representative sample (n = 1,210), we compared by logistic regression the QoL of 48 euthymic and 60 non-euthymic BD outpatients and the general population. Within BD patients, we analyzed the clinical and course-of-illness variables associated with low physical and mental QoL, including manic and depressive symptoms and consumption of addictive substances; in addition, we calculated the partial correlation of the different variables with the dimensional PCS and MCS through multiple linear regression.
RESULTS: Low physical QoL was significantly more frequent among both euthymic [odds ratio (OR) = 3.5; 95% confidence interval (CI): 1.9-6.5] and non-euthymic (OR = 4.0; 95% CI: 2.3-7.0) BD patients than in the general population; the respective values for low mental QoL were OR = 2.2; 95% CI: 1.2-4.0 and OR = 8.5; 95% CI: 4.6-15.7. Low mental QoL was more frequent among non-euthymic than euthymic BD patients (OR = 3.9; 95% CI: 1.6-9.1). Within BD patients, low mental QoL was associated with the length of illness (or early onset), the presence of depressive symptoms, nicotine dependence and the lack of social support.
CONCLUSIONS: Among the BD patients, who experience lower physical and mental QoL even in a euthymic period, the optimal control of depressive symptoms as well as the availability of social support may enhance their well-being.

Entities:  

Mesh:

Year:  2008        PMID: 18657247     DOI: 10.1111/j.1399-5618.2008.00604.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  25 in total

1.  Prevalence of Bipolar Disorder symptoms in Primary Care (ProBiD-PC): A Canadian study.

Authors:  John F Chiu; Pratap R Chokka
Journal:  Can Fam Physician       Date:  2011-02       Impact factor: 3.275

2.  Social Aspect of Functioning Deteriorates More Than Individual Aspect in Patients with Remitted Bipolar Disorder.

Authors:  Arzu Tiğli Filizer; Cem Cerit; Başak Tüzün; Ahmet Tamer Aker
Journal:  Noro Psikiyatr Ars       Date:  2016-06-01       Impact factor: 1.339

3.  Depression symptom ratings in geriatric patients with bipolar mania.

Authors:  Martha Sajatovic; Rayan Al Jurdi; Ariel Gildengers; Rebecca L Greenberg; Thomas Tenhave; Martha L Bruce; Benoit Mulsant; Robert C Young
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-01       Impact factor: 3.485

4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

5.  Genetic association of bipolar disorder with the β(3) nicotinic receptor subunit gene.

Authors:  Sarah M Hartz; Peng Lin; Howard J Edenberg; Xiaoling Xuei; Nanette Rochberg; Scott Saccone; Wade Berrettini; Elliot Nelson; John Nurnberger; Laura J Bierut; John P Rice
Journal:  Psychiatr Genet       Date:  2011-04       Impact factor: 2.458

6.  Emotion perception and quality of life in bipolar I disorder.

Authors:  Daniel Fulford; Andrew D Peckham; Kaja Johnson; Sheri L Johnson
Journal:  J Affect Disord       Date:  2013-09-07       Impact factor: 4.839

Review 7.  Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.

Authors:  Eduard Vieta; Marc Valentí
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

Review 8.  Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder.

Authors:  Jessica Dagani; Giulia Signorini; Olav Nielssen; Moira Bani; Adriana Pastore; Giovanni de Girolamo; Matthew Large
Journal:  Can J Psychiatry       Date:  2016-07-11       Impact factor: 4.356

9.  The mood stabiliser lithium suppresses PIP3 signalling in Dictyostelium and human cells.

Authors:  Jason S King; Regina Teo; Jonathan Ryves; Jonathan V Reddy; Owen Peters; Ben Orabi; Oliver Hoeller; Robin S B Williams; Adrian J Harwood
Journal:  Dis Model Mech       Date:  2009-04-21       Impact factor: 5.758

10.  Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study.

Authors:  Andrea Fagiolini; Ellen Frank; David A Axelson; Boris Birmaher; Yu Cheng; David E Curet; Edward S Friedman; Ariel G Gildengers; Tina Goldstein; Victoria J Grochocinski; Patricia R Houck; Mary G Stofko; Michael E Thase; Wesley K Thompson; Scott R Turkin; David J Kupfer
Journal:  Bipolar Disord       Date:  2009-06       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.